Obstetrics & Gynaecology Search
Obstetrics & Gynaecology Obstetrics & Gynaecology
pelvic%20inflammatory%20disease
PELVIC INFLAMMATORY DISEASE
Pelvic inflammatory disease (PID) is the ascent of bacteria from the vagina or cervix resulting in infection of the reproductive organs eg uterus, fallopian tubes, ovaries. It may also be a complication of sexually transmitted infections.
The most common symptoms of PID are lower abdominal pain (crampy or dull) that usually starts a few days after the onset of the last menstrual period, dyspareunia, abnormal vaginal or cervical discharge, postcoital or irregular vaginal bleeding, dysuria, fever, nausea and vomiting, although some have minimal symptoms or silent pelvic inflammatory disease.

Pelvic%20inflammatory%20disease Management

Follow Up

  • Further review 4 wk after treatment may be useful to ensure the following:
    • Adequate clinical response
    • Compliance w/ oral antibiotics
    • Screening & treatment of sex partners/contacts
    • Recurrence prevention through condom use
  • Repeat testing for etiologic organisms may be warranted for patients w/ persistent symptoms, poor compliance w/ antibiotics, or possible reinfection
    • In patients w/ documented infection w/ C trachomatis & N gonorrhoeae, some specialists recommend rescreening 4-6 wk after completion of treatment

Counselling

  • STI consultation allows for an opportunity to discuss patient’s risk factors for STIs & HIV
  • Determine patient’s risk for HIV & discuss HIV testing
  • Testing for HIV is recommended & should be offered to all persons seeking evaluation & treatment for STIs
    • Pretest & posttest counseling as well as informed consent are part of the testing procedure
    • Concomitant infection w/ HIV may complicate management & control of some STIs
    • HIV-infected patients w/ PID are more common to have tubo-ovarian abscess & usually require surgical intervention
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Abemaciclib + fulvestrant survival benefit extends to Asians with HR+, HER- ABC
Pearl Toh, 4 days ago
Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.
Acute diarrhoea is the second leading cause of death in children aged younger than 5 years, accounting for approximately 1.9 million deaths worldwide each year; however, diarrhoea is a preventable and treatable condition. In Malaysia, acute gastroenteritis accounts for about 1.3% of all deaths in children aged younger than 5 years annually. Diarrhoea is defined as the passage of three or more loose or watery stools within 24 hours, and it may be clinically categorised as either acute watery diarrhoea (AWD), acute bloody diarrhoea, persistent diarrhoea or diarrhoea with severe malnutrition.
01 Sep 2020
Acute diarrhoea is the second leading cause of deathin children aged younger than 5 years, accounting forapproximately 1.9 million deaths worldwide each year;however, diarrhoea is a preventable and treatable condition.In Malaysia, acute gastroenteritis accounts for about 1.3%of all deaths in children aged younger than 5 years annually.Diarrhoea is defined as the passage of three or more looseor watery stools within 24 hours, and it may be clinicallycategorised as either acute watery diarrhoea (AWD), acutebloody diarrhoea, persistent diarrhoea or diarrhoea withsevere malnutrition.